PUBLISHER: Grand View Research | PRODUCT CODE: 1611050
PUBLISHER: Grand View Research | PRODUCT CODE: 1611050
The global tertiary amines market size is projected to reach USD 6.05 billion by 2030, expanding at a CAGR of 5.8% from 2025 to 2030, according to a new report by Grand View Research, Inc. Widespread use of the product in pharmaceuticals, personal care, agriculture chemicals, pharmaceuticals, and textile fiber industries is projected to drive the growth.
In the pharmaceuticals industry, tertiary amines and their derivatives are used as intermediates for manufacturing medicines. The derivatives with ring-like structure of aryl group are used for manufacturing drugs, such as rosuvastatin, used for lowering cholesterol; aripiprazole belonging to the class of antipsychotic; and imatinib, used for cancer treatment. Derivatives such as imipramine, amitriptyline, lofepramine, and clomipramine are used for manufacturing anti-depressants.
Asia Pacific tertiary amines market witnessed the fastest growth in 2018 owing to the rapidly growing agricultural chemical industry in emerging economies including China, India, Japan, and South Korea. The presence of key raw material suppliers and manufacturers with massive production capacities is expected to further propel the regional growth.
The personal care application is expected to record significant growth over the forecast period. The rapidly growing personal care industry in emerging economies, such as China and India along with the rising consumer preference for personal hygiene and skincare is expected to drive the demand for tertiary amines demand.